ClinicalTrials.gg
CompletedNCT03420196Updated Oct 14, 2019

Efficacy of a Supervised Physical Therapy Rehabilitation Program vs Nonsupervised in Non-specific Low Back Pain

An interventional study of Supervised exercise program and Non supervised exercise program in Low Back Pain and Physical Activity, sponsored by Universidad de Almeria. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-10-14.

Sponsored by Universidad de Almeria · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 13 studies in Low Back Pain by Universidad de Almeria — none open to participants now, none under way, none of them phase 3. Low Back Pain · Universidad de Almeria.

Enrollment
8th of 13
64 · median 68
Started
2018
with 2 others
No phase
11 of 13
none open now
Registered
6th of 13
by date

Among the 13 studies in Low Back Pain by Universidad de Almeria, this one is the 8th largest by enrollment, is one of 3 that started in 2018, is one of 11 with no phase, and was the 6th registered.

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

None of the 13 studies in Low Back Pain by Universidad de Almeria is open now.

Where they have run

Who these studies take

Of the 333 Low Back Pain studies recruiting now, 92 (28%) set no upper age limit and 211 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 13 studies in Low Back Pain by Universidad de Almeria as a file.
02

Study summary

This study compares the efficacy of a supervised rehabilitation program vs a non supervised rehabilitation program on pain, disability, quality of life and kinesiophobia in patients with non-specific low back pain.

Read the detailed description

Low back pain is one of the most common problems of population, being a priority for health systems. It has got a high prevalence and recurrence, affecting in a social and economic way, and, it is one of principal causes of laboral absenteism. A randomized clinical trial will be conducted comparing a supervised physical therapy rehabilitation program vs a non supervised rehabilitation program.

Objective: to compare the efficacy of a supervised rehabilitation program vs a non supervised rehabilitation program in patients with non-specific low back pain.

Methods: Sixt-four subjects with chronic non-specific low back pain will be assigned to supervised rehabilitation program or non supervised rehabilitation program during 4 weeks (5 sessions/week). Outcomes measures will be the following: disability, pain intensity, fear of movement, quality of life, McQuade Test, and lumbar mobility flexion.

03

Conditions studied

  • Low Back Pain
  • Physical Activity

Keywords

  • low back pain
  • physical therapy
  • randomized clinical trial
  • exercise program
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic non-specific low back pain persisting ≥ 3 months.
  • Age between 18 and 65 years.
  • A score ≥ 4 in Roland Morris Disability Questionnaire.
  • Not currently receiving physical therapy.

Exclusion criteria

Exclusion Criteria:

  • Presence of lumbar stenosis.
  • Presence of clinical signs of radiculopathy.
  • Diagnosis of spondylolisthesis.
  • Diagnosis of fibromyalgia.
  • Treatment with or pharmachological medication within the paset 2 weeks.
  • A history of spinal surgery.
  • Central or peripheral nervous system disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    Supervised Rehabilitation program

    It will be consist in a supervised exercise program by physical therapist, including the following structures: diaphragm, tranverse abdominis muscle, pelvic, gluteus, CORE and spinal mobility

    Other: Supervised exercise program

  • Active comparator
    Nonsupervised rehabilitation program

    It will consist in an exercise program for home, nonsupervised, including the following structures: diaphragm, tranverse abdominis muscle, pelvic, gluteus, CORE and spinal mobility. The patients will perform an exercise program at home.

    Other: Non supervised exercise program

Interventions

  • OtherSupervised exercise program

    It will consist in a supervised exercise program, including the following exercises: * Diaphragmatic breathing. * Transverse abdomLateral leg raise for gluteus mediuminis muscle activation. * Pelvic swing. * Gluteus bridge. * Spinal mobility. * Spinal extensor muscles strengthening * Frontal plank * Side plank. * Lateral leg raise for gluteus medium

  • OtherNon supervised exercise program

    It will consist in a non supervised exercise program, including the following exercises: * Diaphragmatic breathing. * Transverse abdomLateral leg raise for gluteus mediuminis muscle activation. * Pelvic swing. * Gluteus bridge. * Spinal mobility. * Spinal extensor muscles strengthening * Frontal plank * Side plank. * Lateral leg raise for gluteus medium

06

What researchers measure

Primary outcomes

  1. Change from baseline in Roland Morris Disability Questionnaire (RMDQ)

    This is a self-reported questionnaire consisting in 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities

    Time frame: at baseline,immediate post-treatment and at 6 months

Secondary outcomes

  1. Change from baseline in disability. Oswestry Low Back Pain Disability Index.

    It has 10 items associated to activities of daily living, each item has a puntuation fron 0 to 5 points

    Time frame: At baseline, immediate post-treatment and at 6 months

  2. Change from baseline in pain intensity (Visual Analogue Scale).

    A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

    Time frame: At baseline, immediate post-treatment and at 6 months

  3. Change from baseline in Fear of Movement. Tampa Scale of kinesiophobia.

    It is a 17-item questionnaire that measures the fear of movement and (re)injury

    Time frame: At baseline, immediate post-treatment and at 6 months

  4. Change from baseline on Quality of Life.

    SF-36 Health questionnaire scores range from 0 to 100% and indicate the self-perceived health-related quality of life.

    Time frame: At baseline, immediate post-treatment and at 6 months

  5. Change from Mcquade Test

    It measures the isometric endurance of trunk flexion muscles

    Time frame: at baseline, immediate post-treatment and at 6 months

  6. Change from baseline in lumbar mobility flexion

    It is determined by measuring the finger-to-floor distance.

    Time frame: at baseline, immediate post-treatment and at 6 months

07

Study locations

1 site
  • Universidad de Almería
    Almería, Andalucía 04120, Spain
08

References and documents

Publications

  • Delitto A, George SZ, Van Dillen L, Whitman JM, Sowa G, Shekelle P, Denninger TR, Godges JJ; Orthopaedic Section of the American Physical Therapy Association. Low back pain. J Orthop Sports Phys Ther. 2012 Apr;42(4):A1-57. doi: 10.2519/jospt.2012.42.4.A1. Epub 2012 Mar 30. PubMed 22466247 ↗
  • Manchikanti L, Singh V, Falco FJ, Benyamin RM, Hirsch JA. Epidemiology of low back pain in adults. Neuromodulation. 2014 Oct;17 Suppl 2:3-10. doi: 10.1111/ner.12018. PubMed 25395111 ↗
  • Balague F, Mannion AF, Pellise F, Cedraschi C. Non-specific low back pain. Lancet. 2012 Feb 4;379(9814):482-91. doi: 10.1016/S0140-6736(11)60610-7. Epub 2011 Oct 6. PubMed 21982256 ↗
  • GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6. Erratum In: Lancet. 2017 Jan 7;389(10064):e1. doi: 10.1016/S0140-6736(16)32606-X. PubMed 27733282 ↗
  • Hu H, Zheng Y, Wang X, Chen B, Dong Y, Zhang J, Liu X, Gong D. Correlations between lumbar neuromuscular function and pain, lumbar disability in patients with nonspecific low back pain: A cross-sectional study. Medicine (Baltimore). 2017 Sep;96(36):e7991. doi: 10.1097/MD.0000000000007991. PubMed 28885356 ↗
  • Jubany J, Danneels L, Angulo-Barroso R. The influence of fatigue and chronic low back pain on muscle recruitment patterns following an unexpected external perturbation. BMC Musculoskelet Disord. 2017 Apr 19;18(1):161. doi: 10.1186/s12891-017-1523-3. PubMed 28420353 ↗
  • Marshall PWM, Schabrun S, Knox MF. Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain. PLoS One. 2017 Jul 7;12(7):e0180788. doi: 10.1371/journal.pone.0180788. eCollection 2017. PubMed 28686644 ↗
  • Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976). 1983 Mar;8(2):141-4. doi: 10.1097/00007632-198303000-00004. No abstract available. PubMed 6222486 ↗
  • Roland M, Morris R. A study of the natural history of low-back pain. Part II: development of guidelines for trials of treatment in primary care. Spine (Phila Pa 1976). 1983 Mar;8(2):145-50. doi: 10.1097/00007632-198303000-00005. PubMed 6222487 ↗
  • Roland M, Fairbank J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3115-24. doi: 10.1097/00007632-200012150-00006. No abstract available. Erratum In: Spine 2001 Apr 1;26(7):847. PubMed 11124727 ↗
  • Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952. doi: 10.1097/00007632-200011150-00017. PubMed 11074683 ↗
  • Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available. PubMed 11124729 ↗
  • Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc). 1995 May 27;104(20):771-6. Spanish. PubMed 7783470 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2018 to primary completion in Jan 2019, 11 months.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 11 months is close to that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2018
First posted
Feb 5, 2018
StartActual
Feb 1, 2018
Primary completionActual
Jan 31, 2019
CompletionActual
Apr 1, 2019
Last update
Oct 14, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03420196
Lead sponsor
Universidad de Almeria
Responsible party
Adelaida María Castro-Sánchez (PhD (Lecturer), Universidad de Almeria) — Principal investigator
First posted
Feb 5, 2018
Start date
Feb 1, 2018
Primary completion
Jan 31, 2019
Completion
Apr 1, 2019
Last update
Oct 14, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion